RxDoctor Payments Data

Barbara Oneill

Family · Fredericksburg, VANPI 1184241994

Payments from drug & device makers

$4,916in general payments, 2019–2025

Across 136 payments — averaging $36.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$408
  • Philips North America LLC$394
  • Abbott$308
  • Amgen$295
  • Novo Nordisk$228
  • plus $2K from 22 others

What the payments were for

  • Travel & lodging$3497%
  • Food & beverage$4,43690%
  • Education$1313%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,916 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban382$409,545
XareltoRivaroxaban86$86,782
EntrestoSacubitril/Valsartan37$42,803
FarxigaDapagliflozin Propanediol11$11,960
BrilintaTicagrelor12$8,744
Flecainide Acetate127$5,984
Metoprolol Succinate246$3,801
Midodrine Hcl27$3,170
Atorvastatin Calcium225$2,394
Rosuvastatin Calcium148$1,817
Bumetanide47$1,803
Isosorbide Dinitrate19$1,398
ClopidogrelClopidogrel Bisulfate96$1,338
Amlodipine-ValsartanAmlodipine Besylate/Valsartan13$1,185
Carvedilol151$969

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$41$409,545382 claims
Johnson & JohnsonXarelto$27$86,78286 claims
NovartisEntresto$72$42,80337 claims
AstraZenecaFarxiga, Brilinta$166$20,70423 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,332 family providers in Virginia.

Other family in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →